GENAPAX Drug Patent Profile
When do Genapax patents expire, and what generic alternatives are available?
Genapax is a drug marketed by Key Pharms and is included in one NDA.
The generic ingredient in GENAPAX is gentian violet. There is one drug master file entry for this compound. Additional details are available on the gentian violet profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for GENAPAX?
- What are the global sales for GENAPAX?
- What is Average Wholesale Price for GENAPAX?
Summary for GENAPAX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 1,392 |
| DailyMed Link: | GENAPAX at DailyMed |
US Patents and Regulatory Information for GENAPAX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Key Pharms | GENAPAX | gentian violet | TAMPON;VAGINAL | 085017-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
